182
Views
5
CrossRef citations to date
0
Altmetric
Uveitis

Chemokine and Adhesion Molecule Profiles in Aqueous Humor of Clinically Quiescent Uveitic Cataracts

, , , , &
Pages 194-199 | Received 28 Jun 2018, Accepted 30 Sep 2018, Published online: 18 Oct 2018

References

  • Durrani OM, Tehrani NN, Marr JE, Moradi P, Stavrou P, Murray PI. Degree, duration, and causes of visual loss in uveitis. Br J Ophthalmol. 2004;88(9):1159–62. doi:10.1136/bjo.2003.037226.
  • Carreno E, Portero A, Herreras JM, Garcia-Vazquez C, Whitcup SM, Stern ME, Calonge M, Enriquez-de-Salamanca A. Cytokine and chemokine tear levels in patients with uveitis. Acta Ophthalmol. 2017;95(5):e405–14. doi:10.1111/aos.13292.
  • Suttorp-Schulten MS, Rothova A. The possible impact of uveitis in blindness: a literature survey. Br J Ophthalmol. 1996;80:844–48.
  • Liu X, Zhao C, Xu T, Gao F, Wen X, Wang M, Pei M, Zhang M. Visual prognosis and associated factors of phacoemulsification and intraocular lens implantation in different uveitis entities in Han Chinese. Ocul Immunol Inflamm. 2017;25(3):349–55. doi:10.3109/09273948.2015.1125512.
  • Mora P, Gonzales S, Ghirardini S, Rubino P, Orsoni JG, Gandolfi SA, Majo F, Guex-Crosier Y. Perioperative prophylaxis to prevent recurrence following cataract surgery in uveitic patients: a two-centre, prospective, randomized trial. Acta Ophthalmol. 2016;94(6):e390–4. doi:10.1111/aos.12955.
  • Parkunan SM, Randall CB, Astley RA, Furtado GC, Lira SA, Callegan MC. CXCL1, but not IL-6, significantly impacts intraocular inflammation during infection. J Leukoc Biol. 2016;100(5):1125–34. doi:10.1189/jlb.3A0416-173R.
  • Dewispelaere R, Lipski D, Foucart V, Bruyns C, Frere A, Caspers L, Willermain F. ICAM-1 and VCAM-1 are differentially expressed on blood-retinal barrier cells during experimental autoimmune uveitis. Exp Eye Res. 2015;137:94–102. doi:10.1016/j.exer.2015.06.017.
  • O’Boyle G, Brain JG, Kirby JA, Ali S. Chemokine-mediated inflammation: identification of a possible regulatory role for CCR2. Mol Immunol. 2007;44(8):1944–53. doi:10.1016/j.molimm.2006.09.033.
  • Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the first International workshop. Am J Ophthalmol. 2005;140:509–16.
  • Miao H, Tao Y, Li XX. Inflammatory cytokines in aqueous humor of patients with choroidal neovascularization. MOL VIS. 2012;18:574–80.
  • Hogan MJ, Kimura SJ, Thygeson P. Signs and symptoms of uveitis. I. Anterior uveitis. Am J Ophthalmol. 1959;47:155–70.
  • Akahane M, Watanabe M, Inoue N, Miyahara Y, Arakawa Y, Inoue Y, Katsumata Y, Hidaka Y, Iwatani Y. Association of the polymorphisms of chemokine genes (IL8, RANTES, MIG, IP10, MCP1 and IL16) with the pathogenesis of autoimmune thyroid diseases. Autoimmunity. 2016;49(5):312–19. doi:10.3109/08916934.2015.1134507.
  • Bronze-da-Rocha E, Novoa A, Teixeira N, Vasconcelos CS, Cerveira C, Castro EMJ, Carvalho MC. Evaluation of the reactivity of sera from patients with systemic lupus erythematosus against the human MCP1. J Clin Immunol. 2012;32(4):721–28. doi:10.1007/s10875-012-9665-4.
  • Gschwandtner M, Piccinini AM, Gerlza T, Adage T, Kungl AJ. Interfering with the CCL2-glycosaminoglycan axis as a potential approach to modulate neuroinflammation. Neurosci Lett. 2016;626:164–73. doi:10.1016/j.neulet.2016.05.037.
  • Biesiada L, Krasomski G, Tchorzewski H. [Current opinions on immunological processes in rheumatoid arthritis during pregnancy]. Pol Merkur Lekarski. 2001;10:477–79.
  • Verma MJ, Lloyd A, Rager H, Strieter R, Kunkel S, Taub D, Wakefield D. Chemokines in acute anterior uveitis. Curr Eye Res. 1997;16:1202–08.
  • van Kooij B, Rothova A, Rijkers GT, de Groot-Mijnes JD. Distinct cytokine and chemokine profiles in the aqueous of patients with uveitis and cystoid macular edema. Am J Ophthalmol. 2006;142(1):192–94. doi:10.1016/j.ajo.2006.02.052.
  • Santeford A, Wiley LA, Park S, Bamba S, Nakamura R, Gdoura A, Ferguson TA, Rao PK, Guan J-L, Saitoh T, et al. Impaired autophagy in macrophages promotes inflammatory eye disease. Autophagy. 2016;12(10):1876–85. doi:10.1080/15548627.2016.1207857.
  • Zhao J, Chen M, Xu H. Experimental autoimmune uveoretinitis (EAU)-related tissue damage and angiogenesis is reduced in CCL2ˉ/ˉCX₃CR1gfp/gfp mice. Invest Ophthalmol Vis Sci. 2014;55(11):7572–82. doi:10.1167/iovs.14-15495.
  • Ren M, Guo Q, Guo L, Lenz M, Qian F, Koenen RR, Xu H, Schilling AB, Weber C, Ye RD, et al. Polymerization of MIP-1 chemokine (CCL3 and CCL4) and clearance of MIP-1 by insulin-degrading enzyme. Embo J. 2010;29(23):3952–66. doi:10.1038/emboj.2010.256.
  • Li DQ, Tseng SC. Three patterns of cytokine expression potentially involved in epithelial-fibroblast interactions of human ocular surface. J Cell Physiol. 1995;163(1):61–79. doi:10.1002/jcp.1041630108.
  • de Boer JH, Hack CE, Verhoeven AJ, Baarsma GS, de Jong PT, Rademakers AJ, de Vries-Knoppert WA, Rothova A, Kijlstra A. Chemoattractant and neutrophil degranulation activities related to interleukin-8 in vitreous fluid in uveitis and vitreoretinal disorders. Invest Ophthalmol Vis Sci. 1993;34:3376–85.
  • Schwartzman S. Advancements in the management of uveitis. Best Pract Res Clin Rheumatol. 2016;30(2):304–15. doi:10.1016/j.berh.2016.07.005.
  • Degroote RL, Uhl PB, Amann B, Krackhardt AM, Ueffing M, Hauck SM, Deeg CA. Formin like 1 expression is increased on CD4+ T lymphocytes in spontaneous autoimmune uveitis. J Proteomics. 2017;154:102–08. doi:10.1016/j.jprot.2016.12.015.
  • Rezk AF, Kemp DM, El-Domyati M, El-Din WH, Lee JB, Uitto J, Igoucheva O, Alexeev V. Misbalanced CXCL12 and CCL5 chemotactic signals in vitiligo onset and progression. J Invest Dermatol. 2017;137(5):1126–34. doi:10.1016/j.jid.2016.12.028.
  • Connolly KA, Belt BA, Figueroa NM, Murthy A, Patel A, Kim M, Lord EM, Linehan DC, Gerber SA. Increasing the efficacy of radiotherapy by modulating the CCR2/CCR5 chemokine axes. Oncotarget. 2016;7(52):86522–35. doi:10.18632/oncotarget.13287.
  • Adamus G, Manczak M, Machnicki M. Expression of CC chemokines and their receptors in the eye in autoimmune anterior uveitis associated with EAE. Invest Ophthalmol Vis Sci. 2001;42:2894–903.
  • Crane IJ, McKillop-Smith S, Wallace CA, Lamont GR, Forrester JV. Expression of the chemokines MIP-1alpha, MCP-1, and RANTES in experimental autoimmune uveitis. Invest Ophthalmol Vis Sci. 2001;42:1547–52.
  • Xu H, Forrester JV, Liversidge J, Crane IJ. Leukocyte trafficking in experimental autoimmune uveitis: breakdown of blood-retinal barrier and upregulation of cellular adhesion molecules. Invest Ophthalmol Vis Sci. 2003;44:226–34.
  • Kharwar NK, Prasad KN, Singh K, Paliwal VK, Modi DR. Polymorphisms of IL-17 and ICAM-1 and their expression in Guillain-Barre syndrome. Int J Neurosci. 2017;127(8):680–87. doi:10.1080/00207454.2016.1231186.
  • McMurray RW. Adhesion molecules in autoimmune disease. Semin Arthritis Rheum. 1996;25:215–33.
  • Duran I, Martinez-Caceres EM, Rio J, Barbera N, Marzo ME, Montalban X. Immunological profile of patients with primary progressive multiple sclerosis. Expression of adhesion molecules. Brain. 1999;122:2297–307.
  • Sipkins DA, Gijbels K, Tropper FD, Bednarski M, Li KC, Steinman L. ICAM-1 expression in autoimmune encephalitis visualized using magnetic resonance imaging. J Neuro Immunol. 2000;104:1–9.
  • Chen J, Mo R, Lescure PA, Misek DE, Hanash S, Rochford R, Hobbs M, Yung RL. Aging is associated with increased T-cell chemokine expression in C57BL/6 mice. J Gerontol A Biol Sci Med Sci. 2003;58:975–83.
  • Richter V, Rassoul F, Purschwitz K, Hentschel B, Reuter W, Kuntze T. Circulating vascular cell adhesion molecules VCAM-1, ICAM-1, and E-selectin in dependence on aging. Gerontology. 2003;49(5):293–300. doi:10.1159/000071710.
  • Miles EA, Rees D, Banerjee T, Cazzola R, Lewis S, Wood R, Oates R, Tallant A, Cestaro B, Yaqoob P, et al. Age-related increases in circulating inflammatory markers in men are independent of BMI, blood pressure and blood lipid concentrations. Atherosclerosis. 2008;196(1):298–305. doi:10.1016/j.atherosclerosis.2006.11.002.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.